Molecular profiling of small bowel adenocarcinomas


Rebecca Feldman Ph.D.1, Igor Astsaturov, M.D. Ph.D.2, Zoran Gatalica, M.D.1

Background: Small-bowel adenocarcinoma (SBA) is a rare malignancy with limited knowledge of the molecular mechanisms or clinical evidence-based guidelines for therapy. We conducted a comprehensive analysis of biomarkers with therapeutic relevance for SBA.

Download Publication